Global Apoptosis Assays Market, By Product (Assay Kits, Reagents, Microplates, Instruments), Technology (Flow Cytometry, Cell Imaging and Analysis Systems, Spectrophotometry, Other Detection Technologies), End User (Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Academic and Research Institutes), Application (Drug Discovery and Development, Clinical and Diagnostic Applications, Basic Research, Stem Cell Research) – Industry Trends and Forecast to 2029.
Apoptosis Assays Market Analysis and Size
Apoptosis assays have numerous applications, including investigative research, disease pathogenesis, diagnostics, and drug discovery. Therapeutically, there is interest in both causing apoptosis to remove unwanted unhealthy cells and avoiding unintentional apoptosis to prevent the death of healthy cells.
Data Bridge Market Research analyses that the apoptosis assays market which was USD 3315.7 million in 2021, is expected to reach USD 6558.41 million by 2029, at a CAGR of 8.9% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Apoptosis Assays Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Assay Kits, Reagents, Microplates, Instruments), Technology (Flow Cytometry, Cell Imaging and Analysis Systems, Spectrophotometry, Other Detection Technologies), End User (Pharmaceutical and Biotechnology Companies, Hospital and Diagnostic Laboratories, Academic and Research Institutes), Application (Drug Discovery and Development, Clinical and Diagnostic Applications, Basic Research, Stem Cell Research)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), Bio-Rad Laboratories (U.S.), General Electric (U.S.), Sartorius AG (Germany), Danaher (U.S.), Geno Technology Inc. (U.S.), GeneCopoeia, Inc. (U.S.), Bio-Techne (U.S.), BioTek (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Biotium (U.S.), Abcam plc (U.K.) and Creative Bioarray (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Apoptosis assays cell-based apoptosis detection assays apoptosis, also known as programmed cell death, is a growth-limiting regulatory mechanism in which cells can kill themselves in response to extracellular signals due to irreversible cellular or DNA damage. Apoptosis inhibition causes cells to snub internal or external stimuli that would normally initiate apoptosis. This results in the survival and proliferation of damaged cells, increasing the likelihood of diseases such as cancer. As a result, many anti-cancer strategies in drug development focus on restoring apoptosis in order to cause cell death in these specific cell populations and shrink tumours.
Global Apoptosis Assays Market Dynamics
Drivers
- Rising advent of novel radionuclide tracers
The introduction of novel radionuclide tracers, such as caspase inhibitors and radiolabeled annexin V, has improved the proficiency of real-time monitoring of cellular death. For instance, ANNEXIN V kits have undergone various modifications, rising preference for radiolabeled ANNEXIN V kits. Controlling and understanding the mechanisms is involved in different steps of apoptosis aids in the novel drug discoveries. Also, the rise in the demand for caspase activity assays along with Bcl-2 protein family across pharmaceutical companies for cell death detection has boosted the market growth.
- Rise in innovative assay kits
Significant investment by market players in the development of innovative and affordable assay kits, coupled with a rising preference for apoptosis assay kits among users, is expected to contribute to the global market. Various kit manufacturers have developed an extensive product line that includes novel reagents that can improve cell-death detection and monitoring, because reagents are an essential component of apoptosis assay protocols. This is expected to boost the apoptosis assay market during the forecast period.
Opportunities
- Growing adoption of apoptosis assays
The high adoption of apoptosis assays in developing markets will create several opportunities that will lead to the growth of the apoptosis assays market in the forecast period due to factors such as the increasing prevalence of infectious and chronic diseases, rising funding for cancer research, and increasing cell-based research.
Restraints/Challenges
- Lack of skilled personnel for research and development
Dearth of skilled personnel for research and development of apoptosis assays. Cells can undergo apoptosis or necrosis due to the cells that die due to acute injury typically swell and burst and undergo necrosis. These all factors will obstruct the market's growth rate.
This apoptosis assays market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the apoptosis assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Apoptosis Assays Market Scope
The apoptosis assays market is segmented on the basis of product, technology, end user and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Assay Kits
- Caspase Assays
- Annexin V and Cell Permeability Assays
- DNA Fragmentation Assays
- Mitochondrial Assays
- Reagents
- Microplates
- Instruments
Technology
- Flow Cytometry
- Cell Imaging and Analysis Systems
- Spectrophotometry
- Other Detection Technologies
End User
- Pharmaceutical and Biotechnology Companies
- Hospital and Diagnostic Laboratories
- Academic and Research Institutes
Application
- Drug Discovery and Development
- Clinical and Diagnostic Applications
- Basic Research
- Stem Cell Research
Apoptosis Assays Market Regional Analysis/Insights
The apoptosis assays market is analysed and market size insights and trends are provided by country, product, technology, end user and application as referenced above.
The countries covered in the apoptosis assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the apoptosis assays market because of the rising research and development activities in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the growing demand from the healthcare industry and pharmaceutical industry.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The apoptosis assays market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for apoptosis assays market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the apoptosis assays market. The data is available for historic period 2010-2020.
Competitive Landscape and Apoptosis Assays Market Share Analysis
The apoptosis assays market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to apoptosis assays market.
Some of the major players operating in the apoptosis assays market are:
- Merck KGaA (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- BD (U.S.)
- Bio-Rad Laboratories (U.S.)
- General Electric (U.S.)
- Sartorius AG (Germany)
- Danaher (U.S.)
- Geno Technology Inc. (U.S.)
- GeneCopoeia, Inc. (U.S.)
- Bio-Techne (U.S.)
- BioTek (U.S.)
- PerkinElmer Inc. (U.S.)
- Promega Corporation (U.S.)
- Biotium (U.S.)
- Abcam plc (UK)
- Creative Bioarray (U.S.)
SKU-